Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Get Free Report) have received a consensus rating of “Hold” from the nine brokerages that are covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $21.1111.
Several equities analysts recently commented on the company. Wells Fargo & Company upped their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Cantor Fitzgerald started coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price objective for the company. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Saturday, January 3rd. UBS Group assumed coverage on shares of Sabra Healthcare REIT in a research report on Tuesday, November 18th. They issued a “neutral” rating and a $20.00 target price on the stock. Finally, Truist Financial boosted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a report on Tuesday.
Check Out Our Latest Analysis on Sabra Healthcare REIT
Institutional Inflows and Outflows
Sabra Healthcare REIT Stock Performance
NASDAQ:SBRA opened at $19.21 on Friday. The company has a debt-to-equity ratio of 0.92, a current ratio of 5.19 and a quick ratio of 5.19. The firm has a market cap of $4.79 billion, a PE ratio of 26.68, a P/E/G ratio of 1.17 and a beta of 0.67. The firm has a 50 day simple moving average of $19.03 and a 200-day simple moving average of $18.69. Sabra Healthcare REIT has a 1-year low of $15.60 and a 1-year high of $19.97.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last released its earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 EPS for the quarter, topping the consensus estimate of $0.37 by $0.01. The firm had revenue of $190.04 million during the quarter, compared to analysts’ expectations of $193.44 million. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. Sabra Healthcare REIT’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. On average, equities analysts expect that Sabra Healthcare REIT will post 1.45 EPS for the current year.
Sabra Healthcare REIT Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Monday, November 17th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Monday, November 17th. This represents a $1.20 annualized dividend and a dividend yield of 6.2%. Sabra Healthcare REIT’s payout ratio is currently 166.67%.
About Sabra Healthcare REIT
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.
Featured Articles
- Five stocks we like better than Sabra Healthcare REIT
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
